Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 173 participants.
Also called NCT04069078
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 173 participants
- Sponsor
- Registry
-
NCT04069078
-
- Other papers using this trial's data
- Hemodynamic and antiemetic effects of prophylactic hyoscine butyl-bromide during cesarean section under spinal anesthesia: a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT04069078. Randomized; triple masking; primary purpose prevention. Start 2019-10-10 (actual); primary completion 2020-02-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section
- Condition
- Bradycardia
- Condition
- Spinal Anesthetics Causing Adverse Effects in Therapeutic Use
- Condition
- Cesarean Section Complications
- Intervention (Drug)
- Hyoscine Butylbromide 20 Mg/mL Solution for Injection Ampoule
- Intervention (Other)
- Normal saline
- Lead sponsor
- Assiut University
Record details
- Record id
cardio:ct-nct04069078- Content hash
da3c1c5d99f1e3b2656c5eae0b5a18843fc4c1ad2d16d53584f4282ea1153aef